Canntab is a private Canadian company, which has developed a patent-pending oral sustained-release formulation for cannabinoids . Most conventional (immediate-release) dosage forms, such as tablets and capsules, release the active drug component immediately after oral administration. Canntab’s … Read More
The post Telferscot Signs Letter of Intent with Canntab Therapeutics Limited appeared first on Dagga Magazine.